UK markets close in 7 hours 1 minute
  • FTSE 100

    7,193.30
    -29.80 (-0.41%)
     
  • FTSE 250

    22,935.08
    -31.59 (-0.14%)
     
  • AIM

    1,235.85
    -2.24 (-0.18%)
     
  • GBP/EUR

    1.1858
    -0.0005 (-0.04%)
     
  • GBP/USD

    1.3801
    -0.0025 (-0.18%)
     
  • BTC-GBP

    47,537.27
    +830.32 (+1.78%)
     
  • CMC Crypto 200

    1,544.08
    +63.27 (+4.27%)
     
  • S&P 500

    4,536.19
    +16.56 (+0.37%)
     
  • DOW

    35,609.34
    +152.03 (+0.43%)
     
  • CRUDE OIL

    82.84
    -0.58 (-0.70%)
     
  • GOLD FUTURES

    1,784.70
    -0.20 (-0.01%)
     
  • NIKKEI 225

    28,708.58
    -546.97 (-1.87%)
     
  • HANG SENG

    26,017.53
    -118.49 (-0.45%)
     
  • DAX

    15,498.58
    -24.34 (-0.16%)
     
  • CAC 40

    6,680.53
    -25.08 (-0.37%)
     

Organophosphate and Carbamate Poisoning Drugs In Development, 2021 - ResearchAndMarkets.com

·3-min read

DUBLIN, September 17, 2021--(BUSINESS WIRE)--The "Organophosphate and Carbamate Poisoning (Other Diseases) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information on the therapeutics under development for Organophosphate and Carbamate Poisoning (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Organophosphate and Carbamate Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Organophosphate and Carbamate Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Preclinical stages are 5 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.

The guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Report Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Organophosphate and Carbamate Poisoning (Toxicology).

  • The pipeline guide reviews pipeline therapeutics for Organophosphate and Carbamate Poisoning (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

  • The pipeline guide reviews key companies involved in Organophosphate and Carbamate Poisoning (Toxicology) therapeutics and enlists all their major and minor projects.

  • The pipeline guide evaluates Organophosphate and Carbamate Poisoning (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

  • The pipeline guide reviews the latest news related to pipeline therapeutics for Organophosphate and Carbamate Poisoning (Toxicology)

Key Topics Covered:

Introduction

Organophosphate and Carbamate Poisoning - Overview

Organophosphate and Carbamate Poisoning - Therapeutics Development

  • Pipeline Overview

  • Pipeline by Companies

  • Pipeline by Universities/Institutes

  • Products under Development by Companies

  • Products under Development by Universities/Institutes

Organophosphate and Carbamate Poisoning - Therapeutics Assessment

  • Assessment by Target

  • Assessment by Mechanism of Action

  • Assessment by Route of Administration

  • Assessment by Molecule Type

Organophosphate and Carbamate Poisoning - Companies Involved in Therapeutics Development

  • AntoXa Corp

  • Countervail Corp

  • PlantVax Inc

  • Shanghai Lvdao Pharmaceutical Technology Co Ltd

Organophosphate and Carbamate Poisoning - Drug Profiles

Organophosphate and Carbamate Poisoning - Dormant Projects

Organophosphate and Carbamate Poisoning - Discontinued Products

Organophosphate and Carbamate Poisoning - Product Development Milestones

Featured News & Press Releases

For more information about this report visit https://www.researchandmarkets.com/r/xy3qpx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210917005235/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting